Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

UPC Stock Annual Income Statement. Download in Excel

Universe Pharmaceuticals Inc logo

Universe Pharmaceuticals Inc

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

4.20
 
USD
  
-0.02
  
(-0.47%)
Previous close: 4.22  Open: 4.24  Bid: 3.86  Ask: 4.3
52 week range    
2.51   
   2,592.00
Mkt Cap: 3 M  Avg Vol (90 Days): 349,567
Last updated: Friday 6th June 2025

Stock Rankings

34
MarketXLS Rank
45
Technical
23
Quality
How are these ranks calculated?
Financials

UPC Income Statement

Annual
Invalid dateSep-21Sep-22Sep-23Dec-24
Amortization of intangibles-5523.0
Basic EPS from continuing operations-1.7-626.96
Basic EPS total-0.4-1.7-626.96
Basic weighted shares outstanding5272.022 M4 M13920.0
Cost of sales23 M18 M22 M17 M
Depreciation-441355.0
DepreciationAndAmortization-441355.0
Diluted EPS total2160.0-0.4-1.7-626.96
Diluted normalized net income/share2160.0-1.7-626.96
Diluted weighted shares outstanding5240.022 M4 M13920.0
Earnings from equity interest30827.038588.031072.031942.0
EarningsFromEquityInterestNetOfTax30827.038588.031072.031942.0
GainOnSaleOfPPE-1559.0
GainOnSaleOfSecurity38530.0
GeneralAndAdministrativeExpense3 M3 M2 M3 M
Gross operating profit25 M22 M10 M6 M
Income before tax14 M-8 M-4 M-8 M
Income taxes2 M752419.02 M606704.0
Interest income145476.0
InterestExpenseNonOperating101604.0162400.0156788.0278172.0
MiscOtherSpecialCharges239549.0-470477.0
Net income from total operations11 M-9 M-6 M-9 M
NetIncomeCommonStockholders11 M-9 M-6 M-9 M
NetIncomeContinuousOperations11 M-9 M-6 M-9 M
NetNonOperatingInterestIncomeExpense-101604.0-162400.0-156788.0-132696.0
Normalized income-3 M-8 M
Operating income14 M-7 M-4 M-8 M
Operating income before depreciation (EBITDA)14 M-7 M-3 M-7 M
OperatingExpense12 M29 M14 M14 M
Other income net-270376.0-802302.0273315.0-31942.0
OtherCostofRevenue22 M17 M
OtherGandA3 M3 M2 M3 M
OtherOperatingExpenses80434.0-48940.0235614.0
PromotionAndAdvertising-1 M
RentAndLandingFees3 M
Research & development expense5 M8 M5 M3 M
ResearchExpense5 M8 M5 M3 M
Revenue per share-5523.0
Selling Gen & administrative expense6 M22 M9 M11 M
SellingAndMarketingExpense3 M19 M7 M8 M
SellingExpense3 M19 M
Total Income available for interest expense (EBIT)14 M-8 M-4 M-8 M
Total common shares outstanding6041.022 M42880.0
Total net income11 M-9 M-6 M-9 M
Total ordinary shares563338.0563338.0563338.0563338.0
Total revenues48 M40 M32 M23 M
TotalExpenses34 M47 M36 M31 M
TotalRevenue48 M40 M32 M23 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader